511
Participants
Start Date
May 31, 2015
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
University of Ottawa Heart Institute, Ottawa
Genome Canada
OTHER
Roche Diagnostics GmbH
INDUSTRY
Ottawa Heart Institute Research Corporation
OTHER